Literature DB >> 19346259

Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2).

Stefen A Boehme1, Karin Franz-Bacon, Edward P Chen, Tai Wei Ly, Yuko Kawakami, Kevin B Bacon.   

Abstract

Mast cells are bone marrow-derived effector cells that can initiate inflammatory responses to infectious organisms or allergens by releasing a multitude of pro-inflammatory factors including prostaglandin (PG) D(2). We demonstrate that primary murine bone marrow-derived mast cells (BMMCs) express the PGD(2) receptor; chemoattractant receptor-homologous molecule expressed on T(h) class 2 cells (CRT(h)2). Activation of CRT(h)2 on BMMC by PGD(2) or the CRT(h)2-specific agonist, 13,14-dihydro-15-keto-prostaglandin D(2) (DK-PGD(2)), resulted in signaling response including Ca(2+) mobilization and phosphorylation of the p42/p44 extracellular signal-regulated kinases (ERKs) kinases. Phosphorylation of the ERKs could be blocked by pertussis toxin, as well as a small molecule antagonist of CRT(h)2, Compound A. Activation of CRT(h)2 on BMMC also resulted in the up-regulation of CD23 and CD30 on the cell surface, as well as CD62L shedding. Finally, PGD(2) and DK-PGD(2) induced the migration of BMMC in vitro and in vivo in response to an intra-dermal DK-PGD(2) injection. Both these processes were inhibited by the CRT(h)2 antagonist. These results raise the possibility that the functional consequences of the PGD(2)-CRT(h)2 interaction on mast cells may be relevant in allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346259     DOI: 10.1093/intimm/dxp031

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

Review 1.  Protective and pathological roles of mast cells and basophils.

Authors:  David Voehringer
Journal:  Nat Rev Immunol       Date:  2013-04-05       Impact factor: 53.106

2.  The prostaglandin D₂ receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge.

Authors:  Rui He; Michiko K Oyoshi; James Y T Wang; Martin R Hodge; Haoli Jin; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2010-08-14       Impact factor: 10.793

3.  The anti-inflammatory effect of Cheongseoikki-tang ethanol extract on allergic reactions mediated by bone marrow-derived mast cells.

Authors:  Joon-Ho Keum; Ok-Hwa Kang; Sung-Bae Kim; Su-Hyun Mun; Yun-Soo Seo; Ma-Ryong Kim; Jung-Rae Rho; Young-Seob Lee; Chung-Berm Park; Young-Guk Kim; Yong-Il Kim; Sin-Hee Han; Dong-Yeul Kwon
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

4.  The CRTH2 agonist Pyl A prevents lipopolysaccharide-induced fetal death but induces preterm labour.

Authors:  Lynne Sykes; Bronwen R Herbert; David A Macintyre; Emma Hunte; Sathana Ponnampalam; Mark R Johnson; Tiong G Teoh; Phillip R Bennett
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

Review 5.  Mast cells in atopic dermatitis.

Authors:  Toshiaki Kawakami; Tomoaki Ando; Miho Kimura; Bridget S Wilson; Yuko Kawakami
Journal:  Curr Opin Immunol       Date:  2009-10-14       Impact factor: 7.486

6.  Mast cell chemotaxis - chemoattractants and signaling pathways.

Authors:  Ivana Halova; Lubica Draberova; Petr Draber
Journal:  Front Immunol       Date:  2012-05-25       Impact factor: 7.561

7.  Expression of DP2 (CRTh2), a prostaglandin D₂ receptor, in human mast cells.

Authors:  Tae Chul Moon; Eduardo Campos-Alberto; Tsuyoshi Yoshimura; Graeme Bredo; Aja M Rieger; Lakshmi Puttagunta; Daniel R Barreda; A Dean Befus; Lisa Cameron
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 8.  Mast Cells and Their Progenitors in Allergic Asthma.

Authors:  Erika Méndez-Enríquez; Jenny Hallgren
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

9.  Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Erin Lewis; Deborah Gakpo; Jonathan Hacker; Aaqib Sohail; Faith Taliaferro; Evans Berreondo Giron; Chelsea Asare; Marko Vukovic; Jillian C Bensko; Daniel F Dwyer; Alex K Shalek; Jose Ordovas-Montanes; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2021-06-16       Impact factor: 14.290

10.  MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.

Authors:  Stefen A Boehme; Karin Franz-Bacon; Danielle N DiTirro; Tai Wei Ly; Kevin B Bacon
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.